SCHEMBL30847917

SCHEMBL30847917

Cn1ncc2cccc(NS(=O)(=O)c3cnn(-c4cccc(C(F)(F)F)n4)c3)c21

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SLC40A1 Q9NP59 11/20 0.41
▸ PTPN11 Q06124 1/20 0.38
▸ GLO1 Q04760 3/20 0.35
▸ AGTR1 P30556 2/20 0.34
▸ PAX8 Q06710 2/20 0.34
▸ G6PD P11413 1/20 0.34
▸ NFKBIA P25963 1/20 0.34
▸ METAP2 P50579 1/20 0.34
▸ METAP1 P53582 1/20 0.34
▸ ATM Q13315 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ CCR9 P51686 1/20 0.34
▸ CLK1 P49759 1/20 0.34
▸ ACLY P53396 1/20 0.34
▸ BRD4 O60885 1/20 0.34
▸ DDX3X O00571 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27132412 1.00 SLC40A1 (0.41) SLC40A1PTPN11GLO1AGTR1PAX8
SCHEMBL27133421 0.85 SLC40A1 (0.44) SLC40A1PTPN11GLO1CCR9CLK1
SCHEMBL27133773 0.85 SLC40A1 (0.37) SLC40A1PTPN11CLK1DDX3X
SCHEMBL30847799 0.85 SLC40A1 (0.37) SLC40A1PTPN11CLK1DDX3X
SCHEMBL30848094 0.85 SLC40A1 (0.44) SLC40A1PTPN11GLO1CCR9CLK1
SCHEMBL27132411 0.85 SLC40A1 (0.38) SLC40A1PTPN11DDX3X
SCHEMBL27213647 0.84 SLC40A1 (0.40) SLC40A1PTPN11CLK1
SCHEMBL30847992 0.84 SLC40A1 (0.40) SLC40A1PTPN11CLK1
SCHEMBL30847830 0.84 PTPN11 (0.40) SLC40A1PTPN11CCR9
SCHEMBL27139332 0.84 PTPN11 (0.40) SLC40A1PTPN11CCR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577536-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY Hotspot Therapeutics, Inc. (US) 2025-07-02 — — EP disclosed
WO-2024044730-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 — — WO disclosed
Send feedback